Back to Renal / Urologic

Renal / Urologic

Xofigo

Administration of radium-223 (Xofigo) for treatment of bone metastases from castration-resistant prostate cancer, targeting cancer that has spread to bones.

Overview

Administration of radium-223 (Xofigo) for treatment of bone metastases from castration-resistant prostate cancer, targeting cancer that has spread to bones.

What to Expect

The procedure is performed on an outpatient basis under image guidance. Most patients go home the same day and resume light activity within a day or two, rather than the weeks typical after open surgery.

Is It Right for You?

Suitability depends on your imaging, symptoms, and medical history. Our interventional radiologists review each case with your referring physician before recommending treatment.

Related Procedures